Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 146 for Ovarian

Edit search filters
  1. Study Of TJ011133 In Participants With Relapsed/ Refractory Advanced Solid Tumors And Lymphoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Veliparib And Floxuridine In Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, Or Fallopian Tube Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study Of Niraparib Maintenance Treatment In Patients With Advanced Ovarian Cancer Following Response On Front-Line Platinum-Based Chemotherapy

    Jacksonville, FL

  4. Suppression Of Ovarian Function With Either Tamoxifen Or Exemestane Compared With Tamoxifen Alone In Treating Premenopausal Women With Hormone-Responsive Breast Cancer

    Eau Claire, WI

  5. A Study Of Rucaparib In Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer (ARIEL2)

    Jacksonville, FL, Rochester, MN

  6. A Phase Ib Study Of Cobimetinib Administered In Combination With Niraparib, With Or Without Atezolizumab, To Patients With Advanced Platinum-Sensitive Ovarian Cancer

    Jacksonville, FL

  7. A Two-Part Phase 3 Study Of Sofetabart Mipitecan (LY4170156) In Participants With Platinum-Resistant (Part A) And Platinum-Sensitive (Part B) Ovarian Cancer

    Rochester, MN

  8. A Study To Investigate The Safety And Effectiveness Of FE 999049 In Controlled Ovarian Stimulation In Women Aged 35-42 Years Old

    Rochester, MN

  9. A Study Comparing Gemcitabine With Or Without AZD 1775 In Treating Patients With Recurrent Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

    Rochester, MN

  10. Gemini Study To Evaluate The Integration Of Cancer Genetic Testing Into A Cancer Clinical Practice At Mayo Clinic At Arizona

    Scottsdale/Phoenix, AZ, Jacksonville, FL

.

Mayo Clinic Footer